Австралия - английски - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - drospirenone; ethinyloestradiol -

САЩ - английски - NLM (National Library of Medicine)

cardinal health - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - pericyazine - oral suspension - 500microgram/1ml

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - pericyazine - oral solution - 500microgram/1ml

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - pericyazine - oral solution - 2mg/1ml

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - pericyazine - oral solution - 2mg/1ml

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - pericyazine - oral tablet - 2.5mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - pericyazine - oral tablet - 10mg

Южна Африка - английски - South African Health Products Regulatory Authority (SAHPRA)

litha pharma (pty) ltd - tablet - see ingredients - each tablet contains hydrochlorothiazide 25 mg triamterene 50 mg

Израел - английски - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - film coated tablets - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations - - oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who choose to use an oral contraceptive as their method of birth control.- treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. - in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.